Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 37, Issue 4, Pages 492-499
Publisher
Wiley
Online
2017-02-02
DOI
10.1002/phar.1909
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy
- (2016) Robert C. Griggs et al. NEUROLOGY
- Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy
- (2016) David Gloss et al. NEUROLOGY
- Histological effects of givinostat in boys with Duchenne muscular dystrophy
- (2016) Paolo Bettica et al. NEUROMUSCULAR DISORDERS
- Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
- (2016) David W. Hammers et al. Journal of the American Heart Association
- Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study
- (2016) Patricia Hafner et al. PLoS One
- Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy
- (2016) Valeria Ricotti et al. PLoS One
- Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
- (2016) Nathalie M. Goemans et al. PLoS One
- Exon skipping therapy for Duchenne muscular dystrophy
- (2015) Ryszard Kole et al. ADVANCED DRUG DELIVERY REVIEWS
- Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles
- (2015) Christine Péladeau et al. HUMAN MOLECULAR GENETICS
- Second-generation compound for the modulation of utrophin in the therapy of DMD
- (2015) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy
- (2015) Valeria De Arcangelis et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial
- (2015) Gunnar M Buyse et al. LANCET
- G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy
- (2015) Nozomi Hayashiji et al. Nature Communications
- Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
- (2014) Thomas Voit et al. LANCET NEUROLOGY
- Ataluren treatment of patients with nonsense mutation dystrophinopathy
- (2014) Katharine Bushby et al. MUSCLE & NERVE
- Duchenne and Becker Muscular Dystrophies
- (2014) Kevin M. Flanigan NEUROLOGIC CLINICS
- A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
- (2014) Jean K. Mah et al. NEUROMUSCULAR DISORDERS
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
- (2013) Christopher R. Heier et al. EMBO Molecular Medicine
- Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy
- (2013) Maria Gabriela Morales et al. HUMAN MOLECULAR GENETICS
- Glucocorticoid Treatment for the Prevention of Scoliosis in Children with Duchenne Muscular Dystrophy: Long-Term Follow-up
- (2013) David E Lebel et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
- (2013) Gernot Schram et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Unknown
- (2013) Silvia Consalvi et al. MOLECULAR MEDICINE
- Scoliosis in Duchenne muscular dystrophy (DMD)
- (2013) John D. Hsu et al. NEUROMUSCULAR DISORDERS
- Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial
- (2013) Kevin M. Flanigan et al. NEUROMUSCULAR DISORDERS
- Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
- (2013) Richard S. Finkel et al. PLoS One
- Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy
- (2012) Gunnar M. Buyse et al. PEDIATRIC PULMONOLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial
- (2011) Gunnar M. Buyse et al. NEUROMUSCULAR DISORDERS
- Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
- (2011) Jonathon M. Tinsley et al. PLoS One
- Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study
- (2010) Bidisha Banerjee et al. MAGNETIC RESONANCE IMAGING
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
- (2009) Katharine Bushby et al. LANCET NEUROLOGY
- The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy
- (2009) Craig M. McDonald et al. MUSCLE & NERVE
- A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
- (2008) Kathryn R. Wagner et al. ANNALS OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search